Europe Sacral Nerve Stimulation Market Size, Share & Industry Trends Analysis Report By Application (Urinary & Fecal Incontinence, Chronic Anal Fissure), By Product (Devices, and Accessories), By End User, By Country and Growth Forecast, 2023 - 2030

Europe Sacral Nerve Stimulation Market Size, Share & Industry Trends Analysis Report By Application (Urinary & Fecal Incontinence, Chronic Anal Fissure), By Product (Devices, and Accessories), By End User, By Country and Growth Forecast, 2023 - 2030


The Europe Sacral Nerve Stimulation Market would witness market growth of 4.9% CAGR during the forecast period (2023-2030).

The need for sacral nerve stimulation is further fueled by the growing elderly population. People are more likely to experience incontinence and other disorders requiring sacral nerve stimulation as they age. Additionally, aging can weaken the pelvic floor and bladder muscles, increasing the risk of urine incontinence. Technological developments in sacral nerve stimulation are also driving the market's growth. New gadgets like wireless networking, greater battery life, and better programming add modern features. These developments result in improvements in patient outcomes and a rise in market adoption.

A further factor anticipated to drive the market is a surge in patient and healthcare provider knowledge of sacral nerve stimulation. As more patients learn about these devices' advantages, medical professionals advise patients to use them as a therapy option for urinary incontinence issues. This market is expanding due to the availability of advantageous reimbursement schemes. Sacral nerve stimulation is becoming more widely covered by insurance companies and governments, which makes it more accessible to patients. As a result, the market is expanding, and there is an increase in the usage of these gadgets.

The NHS spends over £6.5 billion every year on obesity, the second-leading cancer preventive cause, according to the government's most recent data in June 2023. In England, there are more than one in four adults who are obese (26%) and 23.4% of children who are 10 to 11 years old. This puts a tremendous strain on the health and care systems. Stress incontinence arises as a result of this. The bladder becomes hyperactive as a result of this. In the approaching years, there may be a demand for sacral nerve stimulation in the region due to the region's rising obesity rate and the increased likelihood that overweight and obese people would get UI.

The Germany market dominated the Europe Sacral Nerve Stimulation Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $38.5 Million by 2030. The UK market is estimated to witness a CAGR of 4% during (2023 - 2030). Additionally, The France market would showcase a CAGR of 5.7% during (2023 - 2030).

Based on Application, the market is segmented into Urinary & Fecal Incontinence, Chronic Anal Fissure, and Others. Based on Product, the market is segmented into Devices, and Accessories. Based on End User, the market is segmented into Hospitals, Specialty Clinics, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Axonics, Inc., Beijing PINS Medical Co., Ltd., PZMed, Laborie Medical Technologies, Synapse BioMedical, Inc., Johnson and Johnson, LivaNova PLC, Boston Scientific Corporation, and Saluda Medical Pty Ltd.

Scope of the Study

Market Segments covered in the Report:

By Application
  • Urinary & Fecal Incontinence
  • Chronic Anal Fissure
  • Others
By Product
  • Devices
  • Accessories
By End User
  • Hospitals
  • Specialty Clinics
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Medtronic PLC
  • Axonics, Inc.
  • Beijing PINS Medical Co., Ltd.
  • PZMed
  • Laborie Medical Technologies
  • Synapse BioMedical, Inc.
  • Johnson and Johnson
  • LivaNova PLC
  • Boston Scientific Corporation
  • Saluda Medical Pty Ltd.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Sacral Nerve Stimulation Market, by Application
1.4.2 Europe Sacral Nerve Stimulation Market, by Product
1.4.3 Europe Sacral Nerve Stimulation Market, by End User
1.4.4 Europe Sacral Nerve Stimulation Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis
Chapter 4. Europe Sacral Nerve Stimulation Market by Application
4.1 Europe Urinary & Fecal Incontinence Market by Country
4.2 Europe Chronic Anal Fissure Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe Sacral Nerve Stimulation Market by Product
5.1 Europe Devices Market by Country
5.2 Europe Accessories Market by Country
Chapter 6. Europe Sacral Nerve Stimulation Market by End User
6.1 Europe Hospitals Market by Country
6.2 Europe Specialty Clinics Market by Country
6.3 Europe Others Market by Country
Chapter 7. Europe Sacral Nerve Stimulation Market by Country
7.1 Germany Sacral Nerve Stimulation Market
7.1.1 Germany Sacral Nerve Stimulation Market by Application
7.1.2 Germany Sacral Nerve Stimulation Market by Product
7.1.3 Germany Sacral Nerve Stimulation Market by End User
7.2 UK Sacral Nerve Stimulation Market
7.2.1 UK Sacral Nerve Stimulation Market by Application
7.2.2 UK Sacral Nerve Stimulation Market by Product
7.2.3 UK Sacral Nerve Stimulation Market by End User
7.3 France Sacral Nerve Stimulation Market
7.3.1 France Sacral Nerve Stimulation Market by Application
7.3.2 France Sacral Nerve Stimulation Market by Product
7.3.3 France Sacral Nerve Stimulation Market by End User
7.4 Russia Sacral Nerve Stimulation Market
7.4.1 Russia Sacral Nerve Stimulation Market by Application
7.4.2 Russia Sacral Nerve Stimulation Market by Product
7.4.3 Russia Sacral Nerve Stimulation Market by End User
7.5 Spain Sacral Nerve Stimulation Market
7.5.1 Spain Sacral Nerve Stimulation Market by Application
7.5.2 Spain Sacral Nerve Stimulation Market by Product
7.5.3 Spain Sacral Nerve Stimulation Market by End User
7.6 Italy Sacral Nerve Stimulation Market
7.6.1 Italy Sacral Nerve Stimulation Market by Application
7.6.2 Italy Sacral Nerve Stimulation Market by Product
7.6.3 Italy Sacral Nerve Stimulation Market by End User
7.7 Rest of Europe Sacral Nerve Stimulation Market
7.7.1 Rest of Europe Sacral Nerve Stimulation Market by Application
7.7.2 Rest of Europe Sacral Nerve Stimulation Market by Product
7.7.3 Rest of Europe Sacral Nerve Stimulation Market by End User
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Trials and Approvals:
8.1.6 SWOT Analysis
8.2 Axonics, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Product and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Approvals:
8.2.6 SWOT Analysis
8.3 Beijing PINS Medical Co., Ltd.
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 Saluda Medical Pty Ltd.
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 PZMed
8.5.1 Company Overview
8.5.2 SWOT Analysis
8.6 LivaNova PLC
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 SWOT Analysis
8.7 Boston Scientific Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Johnson & Johnson
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental & Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 SWOT Analysis
8.9 Synapse BioMedical, Inc.
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Laborie Medical Technologies (Patricia Industries) (Investor AB)
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings